Switching from imatinib to nilotinib plus pegylated interferon-α2b in chronic phase CML failing to achieve deep molecular response: clinical and immunological effects

التفاصيل البيبلوغرافية
العنوان:	Switching from imatinib to nilotinib plus pegylated interferon-α2b in chronic phase CML failing to achieve deep molecular response: clinical and immunological effects
المؤلفون:	Geelen, Inge G.P.^{Aff1, IDs00277023051991_cor1}, Gullaksen, Stein-Erik^{Aff2, Aff3}, Ilander, Mette M., Olssen-Strömberg, Ulla, Mustjoki, Satu^{Aff4, Aff6, Aff7}, Richter, Johan, Blijlevens, Nicole M.A., Smit, Willem M., Gjertsen, Bjorn T.^{Aff2, Aff3}, Gedde-Dahl, Tobias, Markevärn, Berit, Koppes, Malika M.A., Westerweel, Peter E., Hjorth-Hansen, Henrik^{Aff14, Aff15}, Janssen, Jeroen J.W.M.
المصدر:	Annals of Hematology. 102(6):1395-1408
قاعدة البيانات:	Springer Nature Journals

كن أول من يترك تعليقا!